Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionDnB Asset Management AS
Latest Disclosed Ownership784,341 shares
Latest Disclosed Value $ 47,570,282
DnB Asset Management AS reports 6.95% increase in ownership of BRM / Bristol-Myers Squibb Company

On May 14, 2026 - DnB Asset Management AS filed a 13F-HR form disclosing ownership of 784,341 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $41,115,155 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 733,347 shares of Bristol-Myers Squibb Company. This represents a change in shares of 6.95% during the quarter. The current value of the position is $37,201,294 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F Bristol-Myers Squibb COM 110122108 784,341 50,994 6.95 47,570 20.26 0.1696
2026-02-05 2025-12-31 13F Bristol-Myers Squibb COM 110122108 733,347 29,696 4.22 39,557 24.65 0.1380
2025-11-12 2025-09-30 13F Bristol-Myers Squibb COM 110122108 703,651 26,719 3.95 31,735 1.27 0.1187
2025-08-12 2025-06-30 13F Bristol-Myers Squibb COM 110122108 676,932 -35,219 -4.95 31,335 -27.86 0.1299
2025-05-15 2025-03-31 13F Bristol-Myers Squibb COM 110122108 712,151 3,020 0.43 43,434 8.29 0.2002
2025-02-12 2024-12-31 13F Bristol-Myers Squibb COM 110122108 709,131 227,521 47.24 40,108 60.96 0.1735
2024-11-12 2024-09-30 13F Bristol-Myers Squibb COM 110122108 481,610 -186,527 -27.92 24,919 -10.20 0.1125
2024-07-05 2024-06-30 13F Bristol-Myers Squibb common 110122108 668,137 332,587 99.12 27,748 52.49 0.1324
2024-04-12 2024-03-31 13F Bristol-Myers Squibb common 110122108 335,550 -191,690 -36.36 18,197 -32.74 0.0949
2024-01-04 2023-12-31 13F Bristol-Myers Squibb common 110122108 527,240 -30,875 -5.53 27,053 -16.49 0.1404
2023-10-13 2023-09-30 13F Bristol-Myers Squibb common 110122108 558,115 34,015 6.49 32,393 -3.35 0.1935
2023-07-10 2023-06-30 13F/A-1 Bristol-Myers Squibb common 110122108 524,100 93,054 21.59 33,516 12.19 0.1927
2023-07-06 2023-06-30 13F Bristol-Myers Squibb common 110122108 524,100 93,054 33,516 0.1972
2023-04-20 2023-03-31 13F Bristol-Myers Squibb common 110122108 431,046 -202,204 -31.93 29,876 -34.43 0.1894
2023-01-12 2022-12-31 13F Bristol-Myers Squibb common 110122108 633,250 -7,327 -1.14 45,562 0.05 0.3212
2022-10-11 2022-09-30 13F Bristol-Myers Squibb common 110122108 640,577 -11,109 -1.70 45,539 -9.25 0.3512
2022-07-08 2022-06-30 13F Bristol-Myers Squibb common 110122108 651,686 9,284 1.45 50,180 6.96 0.3528
2022-04-08 2022-03-31 13F Bristol-Myers Squibb common 110122108 642,402 80,645 14.36 46,915 33.94 0.2790
2022-01-12 2021-12-31 13F Bristol-Myers Squibb common 110122108 561,757 -23,319 -3.99 35,026 1.18 0.2055
2021-10-15 2021-09-30 13F Bristol-Myers Squibb common 110122108 585,076 27,106 4.86 34,619 -7.15 0.2248
2021-07-06 2021-06-30 13F Bristol-Myers Squibb common 110122108 557,970 8,960 1.63 37,284 7.57 0.2470
2021-04-15 2021-03-31 13F Bristol-Myers Squibb common 110122108 549,010 1,372 0.25 34,659 2.03 0.2530
2021-01-19 2020-12-31 13F Bristol-Myers Squibb common 110122108 547,638 -126,287 -18.74 33,970 -16.39 0.2977
2020-10-14 2020-09-30 13F Bristol-Myers Squibb common 110122108 673,925 -14,672 -2.13 40,631 0.35 0.4319
2020-07-08 2020-06-30 13F Bristol-Myers Squibb common 110122108 688,597 199,203 40.70 40,490 48.43 0.4756
2020-04-17 2020-03-31 13F Bristol-Myers Squibb common 110122108 489,394 -1,047,863 -68.16 27,279 -72.36 0.4012
2020-01-13 2019-12-31 13F Bristol-Myers Squibb common 110122108 1,537,257 1,229,945 400.23 98,677 533.23 0.9696
2019-10-16 2019-09-30 13F Bristol-Myers Squibb common 110122108 307,312 -134,794 -30.49 15,584 -22.28 0.1759
2019-07-08 2019-06-30 13F Bristol-Myers Squibb common 110122108 442,106 -458 -0.10 20,050 -5.04 0.2309
2019-04-11 2019-03-31 13F Bristol-Myers Squibb common 110122108 442,564 -156,836 -26.17 21,115 -32.23 0.2406
2019-01-15 2018-12-31 13F Bristol-Myers Squibb common 110122108 599,400 245,435 69.34 31,157 41.79 0.4041
2018-10-10 2018-09-30 13F Bristol-Myers Squibb common 110122108 353,965 32,203 10.01 21,974 23.41 0.2470
2018-07-06 2018-06-30 13F Bristol-Myers Squibb common 110122108 321,762 900 0.28 17,806 -12.26 0.2101
2018-04-11 2018-03-31 13F Bristol-Myers Squibb common 110122108 320,862 -46,500 -12.66 20,295 -9.85 0.2443
2018-01-10 2017-12-31 13F Bristol-Myers Squibb common 110122108 367,362 -68,544 -15.72 22,512 -18.98 0.2714
2017-10-11 2017-09-30 13F Bristol-Myers Squibb common 110122108 435,906 8,900 2.08 27,785 16.78 0.3696
2017-07-06 2017-06-30 13F Bristol-Myers Squibb common 110122108 427,006 -47,000 -9.92 23,793 -7.70 0.3469
2017-04-19 2017-03-31 13F Bristol-Myers Squibb common 110122108 474,006 179,500 60.95 25,776 49.77 0.4051
2017-01-17 2016-12-31 13F Bristol-Myers Squibb common 110122108 294,506 -178,300 -37.71 17,211 -32.49 0.3159
2016-10-28 2016-09-30 13F Bristol-Myers Squibb common 110122108 472,806 84,800 21.86 25,494 -10.67 0.5015
2016-07-08 2016-06-30 13F Bristol-Myers Squibb common 110122108 388,006 114,300 41.76 28,538 63.22 0.6049
2016-04-11 2016-03-31 13F Bristol-Myers Squibb common 110122108 273,706 54,200 24.69 17,484 15.80 0.3652
2016-01-20 2015-12-31 13F Bristol-Myers Squibb common 110122108 219,506 5,900 2.76 15,100 19.41 0.3237
2015-10-21 2015-09-30 13F Bristol-Myers Squibb common 110122108 213,606 24,478 12.94 12,645 0.48 0.3158
2015-07-07 2015-06-30 13F Bristol-Myers Squibb common 110122108 189,128 -10,900 -5.45 12,585 -2.46 0.2774
2015-05-18 2015-03-31 13F Bristol-Myers Squibb common 110122108 200,028 700 0.35 12,902 9.65 0.2872
2015-05-19 2014-12-31 13F Bristol-Myers Squibb common 110122108 199,328 300 0.15 11,766 15.51 0.2663
2015-02-17 2014-09-30 13F Bristol-Myers Squibb common 110122108 199,028 16,500 9.04 10,186 15.04 0.2242
2014-07-07 2014-06-30 13F Bristol-Myers Squibb common 110122108 182,528 58,700 47.40 8,854 34.54 0.1874
2014-01-27 2013-12-31 13F Bristol-Myers Squibb common 110122108 123,828 73,400 145.55 6,581 182.08 0.1546
2013-10-17 2013-09-30 13F Bristol-Myers Squibb common 110122108 50,428 2,100 4.35 2,334 8.06 0.0639
2013-07-31 2013-06-30 13F Bristol-Myers Squibb common 110122108 48,328 48,328 2,160 0.0639
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.